Literature DB >> 29446158

A neuroscience perspective of the gut theory of Parkinson's disease.

Lisa M Smith1, Louise C Parr-Brownlie1.   

Abstract

Parkinson's disease is caused by complex interactions between environmental factors and a genetic predisposition. Environmental factors include exposure to pesticides and toxins, heavy metals and accumulation of iron and/or manganese in the brain. However, accumulating evidence indicates that gut-brain health and function are impaired in Parkinson's disease, often a decade before motor symptoms are diagnosed. We present the gut-brain theory of Parkinson's disease and summarise the peripheral and central nervous system pathology, gastrointestinal symptoms experienced by many Parkinson's patients, the route by which gut-brain dysfunction may occur and changes in gut microbiota that are associated with disease expression. Finally, we consider future gut-based treatments to prevent or slow down the progression of Parkinson's disease and explore whether this knowledge may highlight biomarkers to be included in complex algorithms in the future to assess a person's risk of developing Parkinson's disease.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  biomarker; faecal transplant; microbiome; vagus nerve; α-synuclein

Year:  2018        PMID: 29446158     DOI: 10.1111/ejn.13869

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

Review 1.  Defining Dysbiosis in Disorders of Movement and Motivation.

Authors:  Christopher T Fields; Timothy R Sampson; Annadora J Bruce-Keller; Drew D Kiraly; Elaine Y Hsiao; Geert J de Vries
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 2.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

3.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

Review 4.  Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases.

Authors:  Ellen J Gates; Anna K Bernath; Andis Klegeris
Journal:  Rev Neurosci       Date:  2022-03-21       Impact factor: 4.703

5.  STRUCTURAL BASES OF GASTROINTESTINAL MOTILITY CHANGES IN PARKINSON'S DISEASE: STUDY IN RATS.

Authors:  José Cirlanio Sousa Albuquerque; Tiago Santos Mendes; Maria Girlane Sousa Albuquerque BrandÃo; Annyta Fernandes Frota; Thomas Dominik de Souza Dos Reis; Lissiana Magna Vasconcelos Aguiar; José Ronaldo Vasconcelos da GraÇa
Journal:  Arq Bras Cir Dig       Date:  2021-01-15

Review 6.  Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.

Authors:  Bairong Shen; Yuxin Lin; Cheng Bi; Shengrong Zhou; Zhongchen Bai; Guangmin Zheng; Jing Zhou
Journal:  Genomics Proteomics Bioinformatics       Date:  2019-11-28       Impact factor: 7.691

7.  Is there a close association of depression with either constipation or dysosmia in Parkinson's disease?

Authors:  Ting-Ya Chang; Yi-Huei Chen; Ming-Hong Chang; Ching-Heng Lin
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

Review 8.  Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson's Disease.

Authors:  Anaıs Marie; Morgane Darricau; Katia Touyarot; Louise C Parr-Brownlie; Clémentine Bosch-Bouju
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.